Professor, Psychiatry, Rush Medical College of Rush Univ
Psychiatry
Dr. Philip G. Janicak, MD
|
|
Give Review
Doctor Philip G. Janicak, MD works in the field of Psychiatry. He attended Loyola University Chicago Stritch School of Medicine. He over the years received 3 awards: "Whos Who in Medicine and Healthcare", "Top MD" and "Super Doctor". Philip Janicak is a published doctor and has 101 publications published. The lastest was: 'Protein kinase C in platelets of depressed patients.'
Publications
- A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant Major depressive disorder: durability of benefi...
- Transcranial magnetic stimulation (TMS) for Major depression: a multisite, naturalistic, observational study of quality of life outcome measures in clinical practice.
- Quetiapine for the treatment of acute bipolar mania, mixed episodes and maintenance therapy.
- Adjunctive use of repetitive transcranial magnetic stimulation in depressed adolescents: a prospective, open pilot study.
- Transcranial magnetic stimulation for Major depressive disorder: introduction.
- Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant Major depression: assessment of relapse during a 6-mo...
- Reply regarding "efficacy and safety of transcranial magnetic stimulation in the acute treatment of Major depression: a multisite randomized controlled trial".
- The acute efficacy of aripiprazole across the symptom spectrum of schizophrenia: a pooled post hoc analysis from 5 short-term studies.
- An interview with Philip G. Janicak, MD: Neuromodulation by Norman Sussman, MD.
- Transcranial magnetic stimulation in the acute treatment of Major depressive disorder: clinical response in an open-label extension trial.
- Transcranial magnetic stimulation in the treatment of Major depressive disorder: a comprehensive summary of safety experience from acute exposure, extended exposure, a...
- Efficacy and safety of transcranial magnetic stimulation in the acute treatment of Major depression: a multisite randomized controlled trial.
- Repetitive transcranial magnetic stimulation versus electroconvulsive therapy: efficacy of treatment in nonpsychotic patients with depression.
- Vagus nerve stimulation for severe depression.
- A one-year open-label trial of risperidone augmentation in lithium nonresponder youth with preschool-onset bipolar Disorder.
- The CATIE study and its implications for antipsychotic drug use.
- The role of psychopharmacotherapy in improving the long-term outcome of schizophrenia.
- A pharmacotherapy algorithm for stabilization and maintenance of pediatric bipolar Disorder.
- Deposition of 7-aminoclonazepam and clonazepam in hair following a single dose of Klonopin.
- The behavioral and cognitive effects of two benzodiazepines associated with drug-facilitated sexual assault.
- Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for Major depression: preliminary results of a randomized trial.
- Protein kinase C and phospholipase C activity and expression of their specific isozymes is decreased and expression of MARCKS is increased in platelets of bipolar but ...
- Topiramate plus risperidone for controlling weight gain and symptoms in preschool mania.
- Electroconvulsive Therapy in the Treatment of the Neuroleptic Malignant Syndrome.
- Efficacy of ECT in Psychotic and Nonpsychotic Depression.
- A Response to Overall and Rhoades Regarding Their Comment on the Efficacy of Unilateral vs. Bilateral ECT.
- The borderland of autonomy: medical-legal criteria for capacity to consent.
- Long-term efficacy and safety of iloperidone: an update.
- Effect of trifluoperazine on CSF and plasma HVA levels in schizophrenic subjects.
- A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients...
- Plasma and CSF HVA before and after pharmacological treatment.
- Neuroleptic concentrations in schizophrenic patients: measurements by radioreceptor assay and gas chromatography.
- A longitudinal study of plasma cortisol and Depressive symptomatology by random regression analysis.
- Studies of beta-adrenergic receptors in leukocytes of patients with affective illness and effects of antidepressant drugs.
- Cerebrospinal fluid somatostatin concentrations in schizophrenia and schizoaffective Disorder: the effects of antipsychotic treatment.
- Deposition of 7-aminoflunitrazepam and flunitrazepam in hair after a single dose of Rohypnol.
- IM olanzapine in the treatment of agitation and aggression.
- The Clinician-Administered Rating Scale for Mania (CARS-M): development, reliability, and validity.
- CSF and plasma MHPG, and CSF MHPG index: pretreatment levels in diagnostic groups and response to somatic treatments.
- Efficacy and safety of the new antipsychotics.
- Platelet serotonin-2A receptors: a potential biological marker for suicidal behavior.
- The disturbed medical student--a challenge.
- Relatives of unipolar and bipolar patients have normal pursuit.
- Decreased beta-adrenergic receptors in the leukocytes of depressed patients.
- Trifluoperazine plasma levels and clinical response.
- The efficacy of psychotropic drugs: implications for power analysis.
- Monoamine oxidase and cortisol response in depression and schizophrenia.
- ECT: an assessment of mental health professionals' knowledge and attitudes.
- Plasma levels of fluphenazine during fluphenazine decanoate treatment in schizophrenia.
- Pharmacologic evidence for specificity of pursuit dysfunction to schizophrenia. Lithium carbonate associated with abnormal pursuit.
- Efficacy of ECT: a meta-analysis.
- Failure of urinary MHPG levels to predict treatment response in patients with unipolar depression.
- Pretreatment dexamethasone suppression test as a predictor of response to phenelzine.
- Response of psychotic and nonpsychotic depressed patients to tricyclic antidepressants.
- Response of psychotic and nonpsychotic depression to phenelzine.
- A comparison of thiothixene with chlorpromazine in the treatment of mania.
- A double-blind, placebo-controlled trial of clonidine in the treatment of acute mania.
- Parenteral S-adenosyl-methionine (SAMe) in depression: literature review and preliminary data.
- Effect of treatment with antidepressants and neuroleptics on human leukocyte beta-adrenergic receptors.
- Increased 3H-clonidine binding in the platelets of patients with Depressive and schizophrenic disorders.
- Platelet serotonin-2 receptor binding sites in depression and suicide.
- MAO inhibition and clinical response in depressed patients treated with phenelzine.
- Plasma HVA in psychiatric patients: longitudinal studies.
- Platelet MAO inhibition, urinary MHPG, and leukocyte beta-adrenergic receptors in depressed patients treated with phenelzine.
- Psychotic affective Disorders: assessment and treatment issues.
- Is maintenance antiparkinsonian treatment necessary?
- Steady-state plasma level prediction for haloperidol from a single test dose.
- Effects of unilateral-nondominant vs. bilateral ECT on memory and depression: a preliminary report.
- Drug treatment of the neuroleptic malignant syndrome.
- Benzodiazepines (BZ) for the management of psychosis.
- Blood level monitoring of antipsychotics and antidepressants.
- Behavioral and biochemical effects of methylphenidate in schizophrenic and nonschizophrenic patients.
- A double-blind, randomized, prospective evaluation of the efficacy and safety of risperidone versus haloperidol in the treatment of schizoaffective Disorder.
- Tiagabine, a specific gamma-aminobutyric acid transporter-1 inhibitor, in the treatment of psychosis.
- Calcium channel antagonists for the treatment of bipolar Disorder.
- Quantitation of clonazepam and its Major metabolite 7-aminoclonazepam in hair.
- Elimination of 7-aminoflunitrazepam and flunitrazepam in urine after a single dose of Rohypnol.
- Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group.
- Strategies for treatment-resistant depression.
- Mood stabilizers in the prevention of recurrent affective Disorders: a meta-analysis.
- The prolactin response to fenfluramine in schizophrenia is associated with negative symptoms.
- Hallucinations in the acute schizophrenic-type psychosis: effects of gender and age of illness onset.
- Protein kinase C in platelets of depressed patients.
- Pretreatment plasma homovanillic acid in schizophrenia and schizoaffective Disorder: the influence of demographic variables and the inpatient drug-free period.
- Elevated [3H]inositol 1,4,5-trisphosphate binding sites and expressed inositol 1,4,5-trisphosphate receptor protein level in platelets of depressed patients.
- Verapamil for the treatment of acute mania: a double-blind, placebo-controlled trial.
- CSF neurotensin concentrations and antipsychotic treatment in schizophrenia and schizoaffective Disorder.
- A two-phase, double-blind randomized study of three haloperidol plasma levels for acute psychosis with reassignment of initial non-responders.
- Length of inpatient stay and recidivism among patients with schizophrenia.
- Prediction of haloperidol steady-state levels in plasma after a single test dose.
- Age of illness onset and schizophrenic symptomatology during an inpatient washout period.
- Antipsychotic dosing strategies in acute schizophrenia.
- Relation of serum valproate concentration to response in mania.
- Elevation of CSF somatostatin concentrations in mania.
- A quantitative analysis of clinical drug trials for the treatment of affective Disorders.
- Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group.
- Platelet serotonin-2 receptors in schizophrenia: effects of illness and neuroleptic treatment.
- The relevance of clinical pharmacokinetics and therapeutic drug monitoring: anticonvulsant mood stabilizers and antipsychotics.
- Homovanillic acid in the cerebrospinal fluid: patterns of response after four weeks of neuroleptic treatment.
- The effect of diagnosis and age on the DST: a metaanalytic approach.
Schools
Loyola University Of ChicagoStritch School Of Medicine
McGaw HospLoyola Med Center
Procedures Preformed
- Psychiatric Evaluation
- Transcranial Magnetic Stimulation (TMS)
Conditions Treated
- Major Depressive Disorder
Doctors Specialties
- Psychiatry
Accepted Insurances
- Aetna
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Cofinity PPO
- Choice Care PPO
- Medicare MCR
- United Healthcare
Awards
- Whos Who in Medicine and Healthcare
- Top MD
- Super Doctor
Education
-
Loyola University -
Loyola University Chicago Stritch School of Medicine
Hospital
-
Rush University Medical Center
Helpful Reviews
Similar Doctors
|
|
Dr. Mojgan M. Makki, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Soberekon M. Koko, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hugo A. Solari, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christy A. McMillin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Katherine M. Rye, DO |
|
|
Dr. Fernando A. Ampuero, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Manjit L. Sandhu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sandra L. Sheinin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sarah R. Florence, MD |
|
|
Dr. Trixie M. Lipke, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thodur M. Ranganathan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fernando F. Santaella, MD |
|
|
Dr. Leonid Shvartsman, MD
This Doctor is OpenDoctor Recommended.
|